Webinar: Registration July 9th, 2018 – see full details below:
A Webinar is planned to explain the application process and overall objectives of the call. Applicants can register by sending an email at email@example.com by July 9th, 2018. Details for the July 16, 2018 webinar (1-2 EST) will be provided in advance to interested applicants.
Letter of Intent Deadline: August 10, 2018
Full Application Deadline: October 26, 2018
Anticipated Funding Start Date : Early 2019
Stand Up to Cancer (SU2C) Canada, in partnership with the Canadian Cancer Society (CCS) and the Canadian Institutes of Health Research (CIHR) – Institute of Cancer Research (ICR) are pleased to announce an upcoming new funding opportunity: the Stand Up to Cancer Canada Metastatic Breast Cancer Dream Team.
The SU2C Canada Metastatic Breast Cancer (MBC) Dream Team represents a new, focused effort to implement advances in metastatic breast cancer research as rapidly as possible through the creation of a collaborative, translational, cancer research “Metastatic Breast Cancer Dream Team”. The most talented and promising researchers across Canadian institutions will be assembled into a pan-Canadian Dream Team, forming an optimal configuration of expertise needed to solve key problems in metastatic breast cancer and positively impact patients in the near future.
The successful MBC Dream Team will span multiple disciplines and utilize the new tools of modern biology to attack research questions in a coordinated way. SU2C Canada, CCS and the CIHR believe that this unique Dream Team model will advance scientific research in the interests of both today’s cancer patients and those who may develop cancer in the future.
Total funds of up to $6 million CAD are available from the funders over a 4-year research term. The funds must be used for research at Canadian institutions.
Full Details for this funding opportunity can be found at http://www.aacrcanada.ca/Pages/Funding-Opportunities.aspx